Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
TP
Thomsen Pharma ApS
aktivCVR 40620060AnpartsselskabGravene 20, 5620 GlamsbjergIkke-finansielle holdingselskaber
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK -15k
Latest period
Source details
Source: dk-regnskabsdata-live-40620060-1793900107424
Document: dk-regnskabsdata-40620060-AZzmv7jSrcE9-QwksYyc-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c1
Unit: u5
Net result
DKK -16.3k
Latest period
Source details
Source: dk-regnskabsdata-live-40620060-1793900107424
Document: dk-regnskabsdata-40620060-AZzmv7jSrcE9-QwksYyc-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c1
Unit: u5
Equity
DKK 607.7k
Equity ratio: 93.9%
Source details
Source: dk-regnskabsdata-live-40620060-1793900107424
Document: dk-regnskabsdata-40620060-AZzmv7jSrcE9-QwksYyc-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c4
Unit: u5
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2000 | — | DKK 1.5m |
| 2001 | — | DKK 484k |
| 2002 | — | DKK -540k |
| 2021 | — | DKK 484k |
| 2022 | — | DKK -539.5k |
| 2023 | — | DKK -5.9k |
| 2024 | — | DKK -4m |
| 2025 | — | DKK -16.3k |